Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Lawsuit Against Horizon Pharma

By Pharmaceutical Processing | November 11, 2015

Pharmacy benefit manager Express Scripts filed a lawsuit in the U.S. against Horizon Pharma after claiming that the drugmaker “refused to honour certain contractual obligations” under a rebate agreement. Express Scripts added that it removed Linden Care from its network, saying that the specialty pharmacy mostly dispensed drugs from Horizon and failed to fulfill its contractual agreements.

Express Scripts spokesman Brian Henry noted that the lawsuit is seeking $140 million from Horizon as it looks “to recover money rightfully due its clients.” The pharmacy benefit manager indicated that it is also evaluating several other pharmacies that it said appeared to dispense mostly Horizon medications.

In response, Horizon said it doesn’t have an ownership stake or possess an option to purchase any pharmacy, and all pharmacies that distribute its branded medicines are fully independent. “The notion that Linden Care is a so-called “captive pharmacy” of Horizon Pharma is entirely false,” the drugmaker added.

According to Horizon, the lawsuit relates entirely to a previously disclosed dispute concerning a prior rebate agreement with Express Scripts, adding that it terminated the deal after the pharmacy benefit manager “failed to live up to its contractual obligations.” Horizon said that it is still reviewing the allegations in the complaint, but they are without merit and the company intends to defend itself.

Last month Express Scripts and CVS Health announced that they would be cutting ties with specialty pharmacy distributor Philidor for not complying with the terms of its provider agreement. The move comes in the wake of recent allegations that Valeant Pharmaceuticals uses pharmacies related to Philidor, which the company has an option to buy, to store inventory and record the transactions as sales in order to artificially inflate revenue.

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE